Cargando…
Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial
Background: Patients diagnosed with influenza and upper respiratory tract infections (URTIs) have similar clinical manifestations and biochemical indices and a low detection rate of viral pathogens, mixed infection with diverse respiratory viruses, and targeted antiviral treatment difficulty in the...
Autores principales: | Li, Weinan, Xie, Lihan, Zhu, Xiaoyun, Yang, Yi, Wang, Linqun, Yang, Min, Li, Hengfei, Li, Xucheng, Yan, Guangjun, Wu, Xiongfei, Zhao, Weijun, Zhang, Jilong, Yang, Gang, Guo, Yufei, Li, Chengyin, Wang, Rui, Shi, Lijun, Xiong, Zhili, Xu, Puming, Kong, Wenwen, Cui, Mengdi, Yang, Xi, Ba, Yuanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050362/ https://www.ncbi.nlm.nih.gov/pubmed/37007028 http://dx.doi.org/10.3389/fphar.2023.1133560 |
Ejemplares similares
-
Molecular Mechanism of Dayuan Decoction in the Treatment of Fever Based on Network Pharmacology
por: Ye, Tielin
Publicado: (2022) -
The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic
por: Zhang, Xiao-rui, et al.
Publicado: (2020) -
Qingfei Jiedu Granules fight influenza by regulating inflammation, immunity, metabolism, and gut microbiota
por: Cui, Xuran, et al.
Publicado: (2022) -
Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge
por: Shen, Yinfeng, et al.
Publicado: (2021) -
“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study
por: Ai, Zhongzhu, et al.
Publicado: (2020)